Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

First Private Sector Energy Storage Deployment Contract for Zinc8 Energy Solutions

Second Commercial Agreement in New York City Less than 2 months after the public sector company NYPA (New York Power Authority) announced a Collaboration Agreement with Zinc8 Energy Solutions, a second energy storage deployment contract has now been executed, th...

FAQ: Redefining Long-Duration Energy Storage with Zinc8 President and CEO, Ron MacDonald

Zinc8 Energy Solutions President & CEO Ron MacDonald Q. What is your current view of the energy storage market globally and what are the drivers of growth in this market? A. We are seeing an accelerating growth of renewables worldwide to solve our climate cr...

Zinc8 accepted into the ACRE Cleantech Incubator Program at Urban Future Lab

The bridge to rapidly scale and transform Zinc8 into a market-driven solution for the next-generation smart grid Yesterday after market close, Zinc8 Energy Solutions Inc. announced "Acceptance into New York City’s ACRE Cleantech Incubator ...

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...

A ‘Novel’ Investment In Psychedelic-Inspired Medicines

Stockhouse investors are keenly aware of the booming trend in the psychedelic healthcare space…in many ways the new Cannabis 2.0 over the last 12 – 24 months. Capital markets have taken to them en masse – a market now estimated to be in excess of USD$5 billion and expected ...

The Mining Co. that’s ‘Rocking & Rolling’ in Northern Ontario

A relatively new junior mining explorer has discovered “high-grade gold mineralization” in one of Canada’s most historic and prolific mining regions. And the drill results announced earlier this year at their cornerstone property in Nor...

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials

Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. In a June 11 research note, Dawson James analyst Jason Kolbert reported that Pluristem Therapeutics Inc. (PSTI:NASDAQ) announced the status of COVID-19-infe...

Do Jobless Claims Point to Sluggish Recovery and Accelerating Gold?

Jobless claims paint a much grimmer picture than other pieces of economic data. So, the Fed (and other central banks) will remain dovish for years, which should support gold prices. More and more economic reports show the beginning of the economic recovery in the U.S. Fol...

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

Avadel Pharmaceuticals' shares are trading 30% higher today on news that the FDA agreed to reduce the sample size required for its Phase 3 REST-ON study, accelerating its completion by year-end 2019. Dublin, Ireland-based Avadel Pharmaceuticals Plc (AVDL:NASDAQ) , wh...

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
1 2 3 4 5 6 7 8 9 10 ...